Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2024-11-22 | New | $235,000 | $235,000 | Debt Only | 06b | SEC link |
2023-02-15 | New | $1,050,000 | $1,050,000 | Debt Only | 06b | SEC link |
Name | Role |
---|---|
Richard Carmona | Director |
Jennifer Johnson | Executive |
Jon Saxe | Director |
Jonathan T. Schilling | Director |
Marvin J. Slepian | Director |
Evan Unger | Director, Executive |
Rong Wang | Executive |